Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-1998 | 12-1997 | 12-1996 | 12-1995 | 12-1994 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 420 | 213 | 350 | N/A | N/A |
| Marketable Securities | 250 | 840 | 3,840 | 1,560 | 1,160 |
| Receivables | 560 | 1,060 | 140 | 60 | 50 |
| Inventories | 1,930 | 2,010 | 750 | 780 | 1,280 |
| Other current assets | 170 | -1,103 | -640 | -210 | -600 |
| TOTAL | $3,330 | $3,020 | $4,440 | $2,190 | $1,890 |
| Non-Current Assets | |||||
| PPE Net | 400 | 182 | 194 | N/A | N/A |
| Other Non-Current Assets | 150 | 180 | 40 | 30 | 130 |
| TOTAL | $550 | $362 | $234 | $30 | $130 |
| Total Assets | $3,910 | $3,390 | $4,680 | $2,510 | $2,420 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 800 | 480 | 110 | 130 | 150 |
| Accrued Expenses | 730 | 30 | 40 | 100 | 120 |
| Other current liabilities | 0 | 480 | 610 | 400 | 420 |
| TOTAL | $3,240 | $1,301 | $770 | $660 | $720 |
| Non-Current Liabilities | |||||
| Long Term Debt | 0 | N/A | N/A | N/A | 20 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $20 |
| Total Liabilities | $3,240 | $1,300 | $770 | $660 | $740 |
| Shareholders' Equity | |||||
| Common Shares | 10 | 10 | 10 | 10 | 8 |
| Retained earnings | -37,960 | -27,620 | -24,790 | -22,330 | -20,310 |
| Other shareholders' equity | 0 | -50 | -10 | 0 | -28 |
| TOTAL | $660 | $2,090 | $3,910 | $1,840 | $1,680 |
| Total Liabilities And Equity | $3,900 | $3,390 | $4,680 | $2,500 | $2,420 |